AIM AND SCOPE
The Journal of HIV/AIDS and Infectious Diseases aims to serve as a comprehensive international platform for the publication of high-quality research, clinical studies, and scholarly contributions in the fields of HIV/AIDS, infectious diseases, microbiology, immunology, and public health. The journal is dedicated to advancing scientific understanding of infectious pathogens, improving diagnostic and therapeutic methodologies, and promoting the development of innovative prevention, treatment, and management strategies for HIV/AIDS and other communicable diseases. It seeks to bridge the gap between basic biomedical research and clinical application by encouraging translational and interdisciplinary studies that contribute to improved patient care, disease control, and global health outcomes.
The journal also aims to foster collaboration among researchers, clinicians, epidemiologists, academicians, and healthcare professionals worldwide, enabling the exchange of knowledge and recent advancements in infectious disease research and healthcare practices. Emphasis is placed on scientific rigor, ethical research standards, evidence-based medicine, and the dissemination of findings that have significant clinical, epidemiological, and societal impact.
The journal welcomes original research articles, review articles, case reports, clinical trials, epidemiological studies, short communications, and perspectives related to HIV/AIDS, viral infections, bacterial infections, fungal diseases, parasitic infections, sexually transmitted infections, antimicrobial resistance, vaccine development, immunopathogenesis, emerging and re-emerging infectious diseases, global health, infection prevention, and public health interventions.
Scope of the Journal
The Journal of HIV/AIDS and Infectious Diseases covers a broad range of topics related to HIV/AIDS, infectious diseases, clinical research, epidemiology, diagnostics, therapeutics, prevention strategies, and public health. The journal aims to provide an international platform for researchers, clinicians, academicians, and healthcare professionals to publish high-quality scientific work that advances the understanding, diagnosis, treatment, and prevention of infectious diseases and HIV/AIDS.
The primary areas of interest include, but are not limited to, the following:
HIV infection and AIDS, retrovirology, viral pathogenesis, HIV immunology, HIV epidemiology, opportunistic infections, sexually transmitted infections, emerging and re-emerging infectious diseases, viral infections, bacterial infections, fungal infections, parasitic infections, tropical diseases, respiratory infections, gastrointestinal infections, hospital-acquired infections, antimicrobial resistance, multidrug-resistant organisms, tuberculosis, hepatitis viruses, COVID-19, influenza, zoonotic diseases, neglected tropical diseases, pediatric infectious diseases, maternal and neonatal infections, neurological infections, cardiovascular infections, dermatological infections, urinary tract infections, sepsis, systemic infections, chronic infectious diseases, co-infections, HIV-TB co-infection, HIV-hepatitis co-infection, immunodeficiency disorders, vaccine-preventable diseases, vaccinology, vaccine development, immunotherapy, antiviral therapy, antimicrobial therapy, antiretroviral therapy, precision medicine in infectious diseases, personalized treatment strategies, drug discovery, pharmacology of infectious diseases, clinical trials, translational medicine, molecular diagnostics, microbiology, medical microbiology, clinical microbiology, virology, bacteriology, mycology, parasitology, molecular epidemiology, genomic surveillance, infectious disease genomics, pathogen evolution, microbial genetics, host-pathogen interactions, immune response, inflammation, cytokine biology, biomarkers, diagnostic biomarkers, point-of-care diagnostics, next-generation sequencing, bioinformatics, computational biology, systems biology, artificial intelligence in infectious disease research, machine learning applications in healthcare, big data analytics, telemedicine, digital health, infection prevention and control, public health surveillance, outbreak investigation, pandemic preparedness, global health, travel medicine, occupational health, environmental health, health policy, healthcare delivery, community health, health education, behavioral health, stigma and discrimination related to HIV/AIDS, social determinants of health, health disparities, ethics in infectious disease research, patient privacy, informed consent, healthcare access, and policy and regulation in infectious disease management.
Types of Manuscripts
The journal accepts original research articles, review articles, systematic reviews, meta-analyses, case reports, case series, short communications, clinical studies, technical notes, perspectives, commentaries, and letters to the editor.
Interdisciplinary and Emerging Research
The journal encourages submissions from interdisciplinary and emerging areas that contribute to the advancement of infectious disease research and HIV/AIDS management. Innovative studies integrating clinical medicine, molecular biology, immunology, genomics, public health, epidemiology, biotechnology, and data science are highly encouraged.
Global Perspective and Inclusivity
The journal adopts a global perspective by encouraging contributions from researchers and healthcare professionals worldwide. Infectious diseases and HIV/AIDS remain major global health challenges that disproportionately affect different populations and regions. Studies focusing on regional disease patterns, population-specific findings, healthcare inequalities, and public health interventions are particularly valuable.
By promoting international collaboration, the journal aims to support global efforts in disease prevention, healthcare accessibility, and the reduction of infectious disease burden across diverse communities.
Ethical, Legal, and Social Considerations
The journal recognizes the ethical, legal, and social implications associated with HIV/AIDS and infectious disease research. Topics including patient confidentiality, informed consent, stigma reduction, equitable healthcare access, public health ethics, data protection, and responsible conduct of research are important components of the journal’s scope.
Authors are expected to adhere to established ethical standards and ensure that research involving human participants complies with institutional and international ethical guidelines.
Education and Knowledge Dissemination
The journal is committed to promoting education and continuous knowledge dissemination in the field of HIV/AIDS and infectious diseases. Educational reviews, clinical updates, evidence-based guidelines, and practical insights that support healthcare professionals, researchers, educators, and students are encouraged.
Quality, Integrity, and Scientific Rigor
Maintaining scientific quality, integrity, and transparency is a central principle of the journal. All submissions should demonstrate methodological rigor, originality, clarity, and relevance to the field. The peer review process ensures fair, unbiased, and thorough evaluation of submitted manuscripts.
Encouragement of Collaborative Research
The journal supports collaborative and multidisciplinary research that integrates expertise from clinical medicine, microbiology, epidemiology, immunology, pharmacology, biotechnology, and public health. National and international collaborative studies are encouraged to accelerate scientific discovery and improve patient outcomes.
Adaptability to Advancing Science
The field of infectious diseases is continuously evolving due to emerging pathogens, technological advancements, and changing healthcare challenges. The journal remains adaptable by embracing innovative research areas, advanced diagnostic technologies, novel therapeutic approaches, and evolving public health strategies.
The Journal of HIV/AIDS and Infectious Diseases is committed to advancing scientific knowledge, improving clinical practice, and supporting global health initiatives through the publication of high-quality, impactful, and evidence-based research in the field of infectious diseases and HIV/AIDS.
